23.17
price up icon4.23%   0.9399
pre-market  Pre-mercato:  22.40   -0.7699   -3.32%
loading
Precedente Chiudi:
$22.23
Aprire:
$22.28
Volume 24 ore:
2,832
Relative Volume:
0.13
Capitalizzazione di mercato:
$51.38M
Reddito:
$5.02M
Utile/perdita netta:
$-18.31M
Rapporto P/E:
-5.1148
EPS:
-4.53
Flusso di cassa netto:
$-23.40M
1 W Prestazione:
+17.79%
1M Prestazione:
+33.54%
6M Prestazione:
+56.98%
1 anno Prestazione:
-14.07%
Intervallo 1D:
Value
$22.28
$23.20
Intervallo di 1 settimana:
Value
$18.89
$23.20
Portata 52W:
Value
$12.12
$29.19

Vtv Therapeutics Inc Stock (VTVT) Company Profile

Name
Nome
Vtv Therapeutics Inc
Name
Telefono
336-841-0300
Name
Indirizzo
3980 PREMIER DR, HIGH POINT, NC
Name
Dipendente
23
Name
Cinguettio
@vTvTherapeutics
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
VTVT's Discussions on Twitter

Confronta VTVT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VTVT
Vtv Therapeutics Inc
23.17 51.38M 5.02M -18.31M -23.40M -4.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
496.49 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.86 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
620.97 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
254.85 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.46 24.70B 3.81B -644.79M -669.77M -6.24

Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2019-05-30 Iniziato H.C. Wainwright Buy
2018-04-10 Downgrade Stifel Buy → Hold
2018-03-08 Iniziato ROTH Capital Buy
2018-02-08 Iniziato Northland Capital Outperform
2016-09-26 Iniziato H.C. Wainwright Buy
2015-09-04 Iniziato Canaccord Genuity Buy
2015-08-24 Iniziato Piper Jaffray Overweight
2015-08-24 Iniziato Stifel Buy
Mostra tutto

Vtv Therapeutics Inc Borsa (VTVT) Ultime notizie

pulisher
Apr 22, 2025

vTv Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:VTVT - Benzinga

Apr 22, 2025
pulisher
Apr 16, 2025

vTv Therapeutics (NASDAQ:VTVT) Coverage Initiated at StockNews.com - Defense World

Apr 16, 2025
pulisher
Apr 12, 2025

vTv Therapeutics Appoints Barry Brown as Interim CFO - MSN

Apr 12, 2025
pulisher
Apr 11, 2025

vTv Therapeutics (NASDAQ:VTVT) Coverage Initiated at HC Wainwright - Defense World

Apr 11, 2025
pulisher
Apr 11, 2025

Q1 Earnings Forecast for VTVT Issued By HC Wainwright - Defense World

Apr 11, 2025
pulisher
Apr 09, 2025

HC Wainwright Initiates vTv Therapeutics With Buy Rating, $36 Price Target - MarketScreener

Apr 09, 2025
pulisher
Apr 09, 2025

This Couchbase Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Apr 09, 2025
pulisher
Apr 09, 2025

HC Wainwright & Co. Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation - Nasdaq

Apr 09, 2025
pulisher
Apr 09, 2025

H.C. Wainwright sets $36 target for vTv Therapeutics stock By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 09, 2025

H.C. Wainwright sets $36 target for vTv Therapeutics stock - Investing.com

Apr 09, 2025
pulisher
Apr 04, 2025

(VTVT) Trading Advice - news.stocktradersdaily.com

Apr 04, 2025
pulisher
Mar 27, 2025

vTv Therapeutics (NASDAQ:VTVT) Now Covered by StockNews.com - Defense World

Mar 27, 2025
pulisher
Mar 25, 2025

(VTVT) Trading Signals - news.stocktradersdaily.com

Mar 25, 2025
pulisher
Mar 21, 2025

vTv Therapeutics Inc Reports Q4 2024 EPS of -$0.55, Beating Esti - GuruFocus.com

Mar 21, 2025
pulisher
Mar 21, 2025

vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update - GlobeNewswire

Mar 21, 2025
pulisher
Mar 21, 2025

The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics - Nasdaq

Mar 21, 2025
pulisher
Mar 20, 2025

VTv Therapeutics: Q4 Earnings Snapshot - CTPost

Mar 20, 2025
pulisher
Mar 20, 2025

vTv Therapeutics: A New Dawn for Diabetes Treatment? - AInvest

Mar 20, 2025
pulisher
Mar 20, 2025

VTv Therapeutics: Q4 Earnings Snapshot -March 20, 2025 at 06:02 pm EDT - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

vTv Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

FDA Greenlights vTv Diabetes Drug Trial as Cash Reserves Triple to $36.7M - StockTitan

Mar 20, 2025
pulisher
Mar 20, 2025

vTv Therapeutics Inc. (VTVT) reports earnings - Quartz

Mar 20, 2025
pulisher
Mar 20, 2025

Why Celsius Holdings Stock Popped This Week - The Globe and Mail

Mar 20, 2025
pulisher
Mar 20, 2025

Biotech Stock Roundup: Patient Death Hits SRPT, INCY Study Data & More - Zacks Investment Research

Mar 20, 2025
pulisher
Mar 20, 2025

Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Decreases By 13.6% - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

Biotech Alert: Searches spiking for these stocks today - TipRanks

Mar 19, 2025
pulisher
Mar 19, 2025

StockNews.com Begins Coverage on vTv Therapeutics (NASDAQ:VTVT) - Defense World

Mar 19, 2025
pulisher
Mar 17, 2025

vTv Therapeutics Soars 43% as FDA Lifts Clinical Hold on Diabetes Drug Trial - GuruFocus.com

Mar 17, 2025
pulisher
Mar 17, 2025

Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup - MarketScreener

Mar 17, 2025
pulisher
Mar 17, 2025

Sector Update: Health Care Stocks Rise Late Afternoon - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Sector Update: Health Care -March 17, 2025 at 03:39 pm EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

FDA Lifts Clinical Hold On vTv Therapeutics' Phase 3 Diabetes Trial, Stock Surges - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

FDA Lifts Clinical Hold, vTv Therapeutics (VTVT) Stock Surges - Stocks Telegraph

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics up after FDA lifts clinical hold on its oral diabetes treatment study - Seeking Alpha

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics resumes phase 3 diabetes trial By Investing.com - Investing.com Australia

Mar 17, 2025
pulisher
Mar 17, 2025

VTv Therapeutics Says FDA Lifted Clinical Hold On Cadisegliatin Program For Diabetes - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics stock surges on FDA update By Investing.com - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

Vtv Therapeutics Says FDA Lifts Clinical Hold on Cadisegliatin Program for Diabetes; Shares Up Pre-Bell - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics stock surges on FDA update - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics resumes phase 3 diabetes trial - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics Announces Resumption of CATT1 Phase 3 Trial for Cadisegliatin as Potential First Oral Adjunct Therapy for Type 1 Diabetes - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes - The Manila Times

Mar 17, 2025
pulisher
Mar 17, 2025

FDA Green Light: vTv's Revolutionary Oral Diabetes Drug Back on Track with Faster Timeline - StockTitan

Mar 17, 2025
pulisher
Mar 12, 2025

3 Quality Compounders on Our Buy List - The Globe and Mail

Mar 12, 2025

Vtv Therapeutics Inc Azioni (VTVT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.63
price up icon 0.19%
$69.86
price up icon 0.24%
$32.54
price up icon 1.06%
$24.11
price up icon 2.75%
$104.00
price up icon 1.94%
biotechnology ONC
$249.46
price up icon 1.86%
Capitalizzazione:     |  Volume (24 ore):